US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly ...

Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the ...

A U.S. bankruptcy court rejected the U.S. Justice Department's arguments that Sorrento Therapeutics (OTC:SRNEQ) misrepresented its business location using a P.O. box in Texas in its Chapter 11 ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 0.0% of Sorrento Therapeutics shares are owned by institutional investors.

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent ...

Sorrento Therapeutics, Inc. (Nasdaq: SRNE) together with its subsidiaries (collectively ‘Sorrento’ or the ‘company’) is a clinical stage and commercial biopharmaceutical company developing ...

His background includes positions with NexImmune, Sorrento Therapeutics (OTC:SRNE), and several other biotechnology firms. He is also an accomplished author and patent holder in the field.

With an international approach to open innovation, ImmuneOncia Therapeutics was established in 2016 as a joint venture between Sorrento Therapeutics, Inc., a clinical-stage biopharmaceutical ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any ...